Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Vacasa, Inc. | Director | Class A Common Stock | 30.4K | $279K | $9.19 | May 21, 2024 | Direct |
Adaptive Biotechnologies Corp | Chief Financial Officer | Common Stock | 21.6K | $89.2K | $4.13 | Dec 22, 2021 | Direct |
Adaptive Biotechnologies Corp | Chief Financial Officer | Stock Option (Right to Buy) | 80K | Dec 22, 2021 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
VCSA | Vacasa, Inc. | May 21, 2024 | 1 | $0 | 4 | May 23, 2024 | Director |
VCSA | Vacasa, Inc. | May 23, 2023 | 1 | $0 | 4 | May 24, 2023 | Director |
VCSA | Vacasa, Inc. | May 24, 2022 | 1 | $0 | 4 | May 25, 2022 | Director |
ADPT | Adaptive Biotechnologies Corp | Dec 22, 2021 | 3 | -$227K | 4 | Dec 23, 2021 | Chief Financial Officer |
VCSA | Vacasa, Inc. | Dec 7, 2021 | 0 | $0 | 3 | Dec 7, 2021 | Director |
ADPT | Adaptive Biotechnologies Corp | Nov 9, 2021 | 6 | -$277K | 4 | Nov 12, 2021 | Chief Financial Officer |
ADPT | Adaptive Biotechnologies Corp | Oct 5, 2021 | 6 | -$251K | 4 | Oct 7, 2021 | Chief Financial Officer |
ADPT | Adaptive Biotechnologies Corp | Sep 7, 2021 | 6 | -$470K | 4 | Sep 9, 2021 | Chief Financial Officer |
ADPT | Adaptive Biotechnologies Corp | Aug 10, 2021 | 7 | -$413K | 4 | Aug 12, 2021 | Chief Financial Officer |
ADPT | Adaptive Biotechnologies Corp | Jul 6, 2021 | 7 | -$643K | 4 | Jul 8, 2021 | Chief Financial Officer |
ADPT | Adaptive Biotechnologies Corp | Jun 8, 2021 | 7 | -$596K | 4 | Jun 10, 2021 | Chief Financial Officer |
ADPT | Adaptive Biotechnologies Corp | May 11, 2021 | 7 | -$511K | 4 | May 13, 2021 | Chief Financial Officer |